Hypoglycaemia after initiation of treatment with etanercept in a patient with type 2 diabetes mellitus

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  2007-11-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/ARD.2007.072256PMID 17998221PMCID PMC2095319
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis.

  2006cited by this paper
• Anti-tumor necrosis factor-α blockade improves insulin resistance in patients with rheumatoid arthritis

  2006cited by this paper
• Etanercept (Enbrel): update on therapeutic use

  2000cited by this paper
• Metabolic effects of tumour necrosis factor alpha in NMRI mice.

  1990cited by this paper
• Relationship of hypoglycemia to tumor necrosis factor production and antitumor activity: role of glucose, insulin, and macrophages.

  1985cited by this paper

• Immunosuppressive agents in diabetes treatment: Hope or despair?

  2025cites this paper
• Etanercept versus Methotrexate in the Treatment of Psoriasis and Associated Metabolic Syndrome: 12-Month Open-Label Comparative Study

  2024cites this paper
• Psoriasis in Patients with Metabolic Syndrome or Type 2 Diabetes Mellitus: Treatment Challenges

  2021cites this paper
• Literature review: drug and alcohol-induced hypoglycaemia

  2021cites this paper
• The effect of etanercept and anakinra on experimental type 2 diabetes pathology in rats

  2021cites this paper
• Psoriatic Arthritis and Diabetes Mellitus: A Narrative Review

  2020cites this paper
• Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trials

  2020cites this paper
• Effects of Adalimumab, an Anti-tumour Necrosis Factor-Alpha (TNF-α) Antibody, on Obese Diabetic Rats

  2018cites this paper
• Combined treatment with interleukin-1 and tumor necrosis factor-alpha antagonists improve type 2 diabetes in rats.

  2018cites this paper
• Etanercept-Induced Hypoglycemia in a Patient With Psoriatic Arthritis and Diabetes

  2017cites this paper
• Psoriasis comorbidities: complications and benefits of immunobiological treatment*

  2016cites this paper
• Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes

  2016cites this paper
• Remission of Uncontrolled Type 2 Diabetes Mellitus in a Patient Treated with Tumor Necrosis Factor-Inhibitor: A Case Report

  2015cites this paper
• Systemic therapy of psoriasis in diabetic patients

  2015cites this paper
• Refractory rheumatoid factor positive polyarthritis in a female adolescent already suffering from type 1 diabetes mellitus and Hashimoto’s thyroiditis successfully treated with etanercept

  2013cites this paper
• Development of low blood glucose readings in nine non-diabetic patients treated with tumor necrosis factor-alpha inhibitors: a case series

  2012cites this paper
• Diabetes mellitus risk in rheumatoid arthritis: Reduced incidence with anti–tumor necrosis factor α therapy

  2012cites this paper
• Etanercept-induced hypoglycemia and improved glycemic control in a patient with type 2 diabetes.

  2011cites this paper
• Drug-Induced Hypoglycaemia

  2011cites this paper
• Can early treatment with biologicals modify the natural history of comorbidities?

  2010cites this paper
• Drugs that act on the immune system

  2010cites this paper
• The therapeutic potential of TNF-α antagonists for skin psoriasis comorbidities

  2010cites this paper
• Effects of tumor necrosis factor‐α blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis

  2009cites this paper
• Severe hypoglycemia after initiation of anti-tumor necrosis factor therapy with etanercept in a patient with generalized pustular psoriasis and type 2 diabetes mellitus.

  2009cites this paper
• Persistent hypoglycemia in a patient with diabetes taking etanercept for the treatment of psoriasis.

  2009influential citation
• Recurrent hyperglycemia during adalimumab treatment in a patient with psoriasis.

  2008cites this paper
• 37 - Drugs that act on the immune system: Cytokines and monoclonal antibodies

  2007cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  1996cites this paper
• World Journal of Diabetes

  year unknowncites this paper